Lamotrigine and Lenalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lamotrigine (lamotrigine) and Lenalidomide (lenalidomide). Common drug interactions include general physical health deterioration among females and injection site reaction among males.

The phase IV clinical study analyzes what interactions people have when they take Lamotrigine and Lenalidomide. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Lamotrigine?

Lamotrigine has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 76,639 Lamotrigine users. Check the latest studies of Lamotrigine.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

31 people who take Lamotrigine and Lenalidomide together, and have interactions are studied.

Lamotrigine and Lenalidomide drug interactions.

What are the common drug interactions of Lamotrigine and Lenalidomide, by gender? *:

female:

  1. General physical health deterioration (weak health status)
  2. Hyperkalaemia (damage to or disease of the kidney)
  3. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  4. Thrombocytopenia (decrease of platelets in blood)
  5. Headache (pain in head)
  6. Chest pain
  7. Depression
  8. Diarrhoea
  9. Dyspepsia (indigestion)
  10. Insomnia (sleeplessness)

male:

  1. Injection site reaction
  2. Cellulitis (infection under the skin)
  3. Peripheral swelling
  4. Pyrexia (fever)
  5. Rash
  6. Sleep disorder
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Bacterial infection
  9. Diarrhoea
  10. Dysarthria (speech disorder)

What are the common drug interactions of Lamotrigine and Lenalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Allergic granulomatous angiitis (allergic inflammation of a blood vessel or lymph duct)
  2. Chest pain
  3. Depression
  4. Dyspepsia (indigestion)
  5. Headache (pain in head)
  6. Insomnia (sleeplessness)
  7. Nausea (feeling of having an urge to vomit)
  8. Night sweats (sweating in night)

50-59:

  1. Diarrhoea
  2. Chest pain
  3. Headache (pain in head)
  4. Nausea (feeling of having an urge to vomit)
  5. Pyrexia (fever)
  6. Tooth disorder (tooth disease)
  7. Vomiting

60+:

  1. General physical health deterioration (weak health status)
  2. Hyperkalaemia (damage to or disease of the kidney)
  3. Chest pain
  4. Chills (felling of cold)
  5. Colitis (inflammation of colon)
  6. Cough
  7. Depression
  8. Diarrhoea
  9. Dysarthria (speech disorder)
  10. Dyspepsia (indigestion)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 20 people, 64.52%
  2. Oedema Peripheral (superficial swelling): 4 people, 12.90%
  3. Depression: 4 people, 12.90%
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 12.90%
  5. Tinea Infection (fungal skin infection): 3 people, 9.68%
  6. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 9.68%
  7. Diarrhea: 3 people, 9.68%
  8. Iron Overload: 2 people, 6.45%
  9. Fatigue (feeling of tiredness): 2 people, 6.45%
  10. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Lamotrigine and Lenalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lamotrigine and Lenalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lamotrigine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lenalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lamotrigine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lenalidomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lamotrigine and lenalidomide (the active ingredients of Lamotrigine and Lenalidomide, respectively), and Lamotrigine and Lenalidomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: